Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX-629 in plaque psoriasis
NCT04908514Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- May 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acloproxalap in plaque psoriasis, sponsored by Aldeyra Therapeutics. Started May 2021; status: completed.
02
Drugs
acloproxalap
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04908514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04908514.